Inovio CSO Humeau Laurent Balances Liquidity and Pipeline Confidence with Flurry of February 2026 Stock Trades
Inovio insider moves reveal a liquidity‑focused strategy: chief scientific officer Humeau Laurent buys and sells RSUs, hinting at short‑term cash needs while still backing the company’s vaccine pipeline.
5 minutes to read